Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

Dupilumab reduces COPD exacerbations and Type 2 inflammation biomarkers, with strongest benefit in patients with high ...

The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

The CAAT governance board recommends transitioning from the COPD Assessment Test to the CAAT and using it for patients with ...

A federal judge on Wednesday ruled that former Chicago Ald. Carrie Austin is medically unfit to stand trial on corruption ...

Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...

Lung conditions, like asthma and chronic obstructive pulmonary disease, are more common in women than men. Stephanie Harris, ...

Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.